Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
U.S. Out-Of-Pocket Healthcare Spending Swells to $491 Billion, Up 10%
By Daniel Granderson In 2021, total U.S. out-of-pocket healthcare spending by consumers reached an estimated $491.6 billion, up about 10% from the prior year with continued annual growth of 9.9% expected through 2026. This will result in almost $800 billion of consumer out-of-pocket healthcare spending in 2026, reports leading medical market research publisher Kalorama […]
Infographic: Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)
Learn more about this important market by subscribing to CELL AND GENE THERAPY BUSINESS OUTLOOK, a twice-monthly publication from the leaders at Kalorama Information. This is an exciting time for the cell and gene therapy industry. Its products are transforming the treatment of cancers and genetic diseases, as well as a host of other illnesses […]
$41 Billion U.S. In Vitro Diagnostics (IVD) Market to Grow 5% Through 2025
By Daniel Granderson The IVD market’s growth in key segments in the U.S. has been accelerated due to the COVID-19 pandemic and the need for testing for the coronavirus. The United States is the largest healthcare market in the world with high privatization of payments relative to other major developed countries. The U.S. healthcare […]
COVID-19 Testing Increases Demand in $150 Billion Clinical Laboratory Services Market, Future Growth Linked to Global Economies
The global market for clinical laboratory services grew to an estimated $150.4 billion during 2020, with COVID-19 testing demand increasing the market by more than $26 billion over the year. These findings are according to insights featured in Clinical Laboratory Services Market, 6th Edition, a new report by leading medical market research publisher Kalorama […]
Molecular Diagnostics Market to Reach 28 Billion. We Didn’t Predict That Two Years Ago.
The market for DNA-based tests used for clinical diagnostic purposes has exceeded previous forecasting, due to the COVID-19 crisis. Mid 2019, Kalorama Information’s report projected the market size (all DNA-based tests, revenues to IVD companies) would reach 10.1 billion. We also estimated cancer would be the driver. Instead, Kalorama now projects that market to be […]
Oncologists Urge Faster Biomarker Results for Lung Cancer Patients
Diagnostic testing companies should do a better job of turning around biomarker test results for lung cancer patients, according to a survey reported at the American Society of Clinical Oncology (ASCO) annual meeting on June 4. Out of 170 clinicians polled, the vast majority (98%) said that they felt it was important to get biomarker […]
China Emerging as Vital Point of Care (POC) Market
Reforms in China, along with increasing incidence of cancer, diabetes, heart disease and infectious diseases such as HIV, hepatitis and STDs, provide new opportunities for point-of-care, advanced tests and molecular diagnostics, reports medical market research publisher Kalorama Information. China’s potential as a point of care (POC) market was already growing when the coronavirus […]
AACC releases guidance on kidney injury lab testing
The American Association for Clinical Chemistry (AACC) released guidance on lab testing for acute kidney injury (AKI) patients that proposes new diagnostic thresholds for whether a patient has AKI with creatinine testing. One of the major recommendations is to propose that clinicians use the 20/20 AACC acute kidney injury criteria to determine whether a patient […]
Infographic: Kalorama Information’s Guide to Diagnostic Biomarkers
This infographic is based on the report The World Market for Diagnostic Biomarkers (Tumor, Cardiac, Infectious Disease, AutoImmune, Others) by leading medical market research publisher Kalorama Information. Purchase the report for more insights on the past, present, and future of this important market.
Remote Patient Monitoring and Telehealth: 5 Years of Growth Forecast for $54 Billion Market
Before COVID-19, the telehealth industry was evolving slowly with slight gains annually. Today, the pandemic has thrust the world into a new era of remote life, including managing, monitoring and treating patients and their health conditions at a pace never experienced before. As a result of COVID-19, the global market for patient monitoring and […]